These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1671164)

  • 41. [Effects of bromocriptine and dopamine on pituitary hormone secretion in women].
    Masaoka K; Hosoya N; Mori T; Watanabe H; Ohkura T; Kumasaka T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec; 34(12):2155-62. PubMed ID: 6818310
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of prolactin, thyrotropin subunit, and gonadotropin subunit gene expression by pulsatile or continuous calcium signals.
    Haisenleder DJ; Yasin M; Yasin A; Marshall JC
    Endocrinology; 1993 Nov; 133(5):2055-61. PubMed ID: 8404653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of gonadotropin subunit messenger ribonucleic acid expression in gonadotropin-releasing hormone (GnRH)-deficient female rats: effects of GnRH, galanin, GnRH-associated peptide, neuropeptide-Y, and thyrotropin-releasing hormone.
    Kerrigan JR; Yasin M; Haisenleder DJ; Dalkin AC; Marshall JC
    Biol Reprod; 1995 Jul; 53(1):1-7. PubMed ID: 7545437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The dopamine DA-1 receptor agonist fenoldopam enhances amino-acid-induced hyperemia in dogs.
    Brooks DP; DePalma D
    Pharmacology; 1993 Jul; 47(1):43-9. PubMed ID: 8101655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gonadotropin-releasing hormone-induced stimulation and desensitization of free alpha-subunit secretion mirrors luteinizing hormone and follicle-stimulating hormone in perifused rat pituitary cells.
    Weiss J; Duca KA; Crowley WF
    Endocrinology; 1990 Nov; 127(5):2364-71. PubMed ID: 2121462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Administration of low dose pulsatile gonadotropin-releasing hormone (GnRH) to GnRH-deficient men regulates free alpha-subunit secretion.
    Spratt DI; Chin WW; Ridgway EC; Crowley WF
    J Clin Endocrinol Metab; 1986 Jan; 62(1):102-8. PubMed ID: 2415548
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of dopamine and metoclopramide in polycystic ovary syndrome.
    Barnes RB; Mileikowsky GN; Cha KY; Spencer CA; Lobo RA
    J Clin Endocrinol Metab; 1986 Aug; 63(2):506-9. PubMed ID: 3722335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of gonadotropin-releasing hormone on rat gonadotropin gene transcription in vitro: requirement for pulsatile administration for luteinizing hormone-beta gene stimulation.
    Shupnik MA
    Mol Endocrinol; 1990 Oct; 4(10):1444-50. PubMed ID: 2126596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Possible altered dopaminergic modulation of pituitary function in normal-menstruating women with insulin dependent diabetes mellitus (IDDM).
    Djursing H; Carstensen L; Hagen C; Andersen AN
    Acta Endocrinol (Copenh); 1984 Dec; 107(4):450-5. PubMed ID: 6440390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the human gonadotroph free alpha-subunit secretory pools by administration of gonadotropin hormone-releasing hormone into normal subjects at different phases of the ovarian cycle.
    Balin MS; Scommegna A; Benveniste R
    J Endocrinol Invest; 1989 Jun; 12(6):373-81. PubMed ID: 2504805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of fenoldopam on cecal blood flow and mechanical activity in horses.
    Clark ES; Moore JN
    Am J Vet Res; 1989 Nov; 50(11):1926-30. PubMed ID: 2575878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid sequential intravenous administration of four hypothalamic releasing hormones as a combined anterior pituitary function test in normal subjects.
    Sheldon WR; DeBold CR; Evans WS; DeCherney GS; Jackson RV; Island DP; Thorner MO; Orth DN
    J Clin Endocrinol Metab; 1985 Apr; 60(4):623-30. PubMed ID: 2982903
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone-deficient men.
    Finkelstein JS; Whitcomb RW; O'Dea LS; Longcope C; Schoenfeld DA; Crowley WF
    J Clin Endocrinol Metab; 1991 Sep; 73(3):609-20. PubMed ID: 1908484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of luteal metoclopramide-induced hyperprolactinemia on pituitary and luteal responsiveness to gonadotropin-releasing hormone.
    Caruso A; Lanzone A; Fulghesu AM; Apa R; Guida C; Mancuso S
    Horm Res; 1989; 31(4):169-74. PubMed ID: 2507435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal and endocrine effects of fenoldopam and metoclopramide in normal man.
    Girbes AR; Smit AJ; Meijer S; Reitsma WD
    Nephron; 1990; 56(2):179-85. PubMed ID: 1978736
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased gonadotropin responsiveness to gonadotropin-releasing hormone during fasting in normal subjects.
    Röjdmark S
    Metabolism; 1987 Jan; 36(1):21-6. PubMed ID: 3099123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Divergent influences of the structurally dissimilar calcium entry blockers, diltiazem and verapamil, on thyrotropin- and gonadotropin-releasing hormone-stimulated anterior pituitary hormone secretion in man.
    Veldhuis JD; Borges JL; Drake CR; Rogol AD; Kaiser DL; Thorner MO
    J Clin Endocrinol Metab; 1985 Jan; 60(1):144-9. PubMed ID: 3880562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of pituitary alpha-subunit, beta-luteinizing hormone and prolactin messenger ribonucleic acid by gonadotropin-releasing hormone and estradiol in hypogonadal mice.
    Stanley HF; Lyons V; Obonsawin MC; Bennie J; Carroll S; Roberts JL; Fink G
    Mol Endocrinol; 1988 Dec; 2(12):1302-10. PubMed ID: 2464132
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of the dopamine agonist, lergotrile mesylate, on circulating anterior pituitary hormones in man.
    Thorner MO; Ryan SM; Wass JA; Jones A; Bouloux P; Williams S; Besser GM
    J Clin Endocrinol Metab; 1978 Aug; 47(2):372-8. PubMed ID: 45463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of thyrotropin-releasing hormone and gonadotropin-releasing hormone on serum TSH, PRL, hGH, FSH and LH in primary testicular failure and in hypogonadotrophic hypogonadism.
    Szilágyi G; Szabolcs I; Vydra G; Góth M; Irsy G
    Acta Med Hung; 1984; 41(4):175-83. PubMed ID: 6440114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.